The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study

Código QR

The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study

Kojiro Hashimoto, Norio Sugawara, Masamichi Ishioka, Kazuhiko Nakamura, Norio Yasui-Furukori Department of Neuropsychiatry, Graduate School of Medicine, Hirosaki University, Hirosaki, Japan Abstract: Hyperprolactinemia is a frequent consequence of treatment with antipsychotics. Earlier studies ha...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hashimoto K, Sugawara N, Ishioka M, Nakamura K, Yasui-Furukori N
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2014
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/b1e91c014750410f8e3504db96c98271
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
por: Ishioka M, et al.
Publicado: (2015)

Attitudes toward long-acting injectable antipsychotics among patients with schizophrenia in Japan
por: Sugawara N, et al.
Publicado: (2019)

Effects of Antipsychotics on Arrhythmogenic Parameters in Schizophrenia Patients: Beyond Corrected QT Interval
por: Okayasu H, et al.
Publicado: (2021)

Dietary patterns and schizophrenia: a comparison with healthy controls
por: Tsuruga K, et al.
Publicado: (2015)

Differences in etiological beliefs about schizophrenia among patients, family, and medical staff
por: Tarakita N, et al.
Publicado: (2018)

Parental bonding and attitudes toward suicide among medical college students in Japan
por: Hashimoto K, et al.
Publicado: (2014)

The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan
por: Kudo S, et al.
Publicado: (2015)

Treatment of Symptom Clusters in Schizophrenia, Bipolar Disorder and Major Depressive Disorder With the Dopamine D3/D2 Preferring Partial Agonist Cariprazine
por: Borjanka Batinic, et al.
Publicado: (2021)

Timing of psychoeducation for patients with depression who were treated with antidepressants: when should patients receive psychoeducation
por: Tomita T, et al.
Publicado: (2018)

Sex Differences In Psychoeducation For Patients With Depression: A Comparison Of Frequency And Efficacy Of Psychoeducation
por: Tomita T, et al.
Publicado: (2019)

Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia
por: Kaneda A, et al.
Publicado: (2013)

Not all partial dopamine D2 receptor agonists are the same in treating schizophrenia. Exploring the effects of bifeprunox and aripiprazole using a computer model of a primate striatal dopaminergic synapse
por: Athan Spiros, et al.
Publicado: (2010)

Psychiatrists' awareness of partial and nonadherence to antipsychotic medication in schizophrenia: results from an Asia–Pacific survey
por: Olivares JM, et al.
Publicado: (2013)

The characteristics of understanding of depression among older patients treated with antidepressants: a comparison between older and younger patients
por: Tomita T, et al.
Publicado: (2018)

The Yamaguchi fox/pigeon-imitation test, a brief cognitive performance rating tool, in a community-dwelling population: normative data for Japanese subjects – a preliminary study
por: Ishioka M, et al.
Publicado: (2014)

The Effects of a Novel Non-catechol Dopamine Partial Agonist on Working Memory in the Aged Rhesus Monkey
por: Tara L. Moore, et al.
Publicado: (2021)

Atypical antipsychotics in the treatment of early-onset schizophrenia
por: Hrdlicka M, et al.
Publicado: (2015)

Effects of personality on the association between paroxetine plasma concentration and response
por: Tomita T, et al.
Publicado: (2018)

The association between the subjective memory complaints scale and depressive state and cognitive impairment: a factor analysis
por: Tomita T, et al.
Publicado: (2015)

Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment
por: Kawamata Y, et al.
Publicado: (2021)

Antipsychotics and risk of natural death in patients with schizophrenia
por: Chen Y, et al.
Publicado: (2019)

Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia
por: Xinhua&nbsp;S Ren, et al.
Publicado: (2009)

Attitudes toward metabolic adverse events among patients with schizophrenia in Japan
por: Sugawara N, et al.
Publicado: (2016)

Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia
por: Oda Y, et al.
Publicado: (2015)

Adjunctive aripiprazole versus placebo for antipsychotic-induced hyperprolactinemia: meta-analysis of randomized controlled trials.
por: Xianbin Li, et al.
Publicado: (2013)

Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone
por: Hongkaew Y, et al.
Publicado: (2015)

Predictive Utility of Body Mass Index for Metabolic Syndrome Among Patients with Schizophrenia in Japan
por: Sugawara N, et al.
Publicado: (2020)

Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
por: Ranjbar F, et al.
Publicado: (2015)

Bipolar disorder recurrence prevention using self-monitoring daily mood charts: case reports from a 5 year period
por: Yasui-Furukori N, et al.
Publicado: (2017)

Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone
por: Hong Liu-Seifert, et al.
Publicado: (2009)

Adding metoclopramide to paroxetine induced extrapyramidal symptoms and hyperprolactinemia in a depressed woman: a case report
por: Igata R, et al.
Publicado: (2016)

Interaction between paliperidone extended release and TS-1&reg;, an oral anticancer drug containing a 5-fluorouracil derivative, in a schizophrenic patient
por: Yasui-Furukori N, et al.
Publicado: (2013)

The comparison of glucose and lipid metabolism parameters in drug-naïve, antipsychotic-treated, and antipsychotic discontinuation patients with schizophrenia
por: Wu X, et al.
Publicado: (2014)

The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study
por: Gro&scaron;ić V, et al.
Publicado: (2014)

A positive correlation between serum amyloid β levels and depressive symptoms among community-dwelling elderly individuals in Japan
por: Tsuruga K, et al.
Publicado: (2014)

Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population
por: Kishi T, et al.
Publicado: (2017)

Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia
por: Ascher-Svanum H, et al.
Publicado: (2012)

Serotonin syndrome induced by the readministration of escitalopram after a short-term interruption in an elderly woman with depression: a case report
por: Sato Y, et al.
Publicado: (2015)

Dopamine D2 receptors and the circadian clock reciprocally mediate antipsychotic drug-induced metabolic disturbances
por: Zachary Freyberg, et al.
Publicado: (2017)

Relationship between quality of life and restless legs syndrome among a community-dwelling population in Japan
por: Kubo K, et al.
Publicado: (2016)